Ghana vs Mali: Tuberculosis prevalence rate
Tuberculosis prevalence rate over time
- Ghana
- Mali
How they compare
Ghana currently reports 92 per 1000,000 population, WHO against 90 per 1000,000 population, WHO in Mali, a difference of 2 per 1000,000 population, WHO.
Across all 22 years both countries report, Ghana has been ahead every year.
Ghana ranks 45th and Mali ranks 46th of 53 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Mali | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 258.8 per 1000,000 population, WHO | 123.8 per 1000,000 population, WHO | 135 per 1000,000 population, WHO | Ghana |
| 2000s | 170.1 per 1000,000 population, WHO | 104.4 per 1000,000 population, WHO | 65.7 per 1000,000 population, WHO | Ghana |
| 2010s | 98 per 1000,000 population, WHO | 91 per 1000,000 population, WHO | 7 per 1000,000 population, WHO | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis prevalence rate, Ghana or Mali?
- Ghana, at 92 per 1000,000 population, WHO against 90 per 1000,000 population, WHO in Mali as of 2011.
- What is the difference in tuberculosis prevalence rate between Ghana and Mali?
- 2 per 1000,000 population, WHO, with Ghana ahead.
- How many years of comparable data are there for Ghana and Mali?
- 22 years are reported by both, from 1990 to 2011.
- How do Ghana and Mali rank globally for tuberculosis prevalence rate?
- Ghana ranks 45th and Mali ranks 46th of 53 countries.
- Where does this data come from?
- World Health Organization, Global Tuberculosis Control Report, published as Tuberculosis prevalence rate (per 1000,000 population, WHO). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as the rate per 100 000 population. It is sometimes referred to as "point prevalence". Estimates include cases of TB in people with HIV. Published values are rounded to three significant figures. Uncertainty bounds are provided in addition to best estimates.